TARS1 is significantly expressed in a number of malignancies, including breast cancer, and is associated with poor prognoses TARS1 overexpression was linked to bigger primary tumor size, hormone receptor negativity, and HER-2 receptor positivity, according to further study of the clinicopathological characteristics of BC patients. Here, TARS1 is linked to neoplasm.